1. Sesquiterpene lactones as emerging biomolecules to cease cancer by targeting apoptosis
   Chou-Yi Hsu et al, 2024, Frontiers in Pharmacology CrossRef
2. Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases
   Vesna Risso et al, 2022, Cell Death & Disease CrossRef
3. Recent Advances in Marine-Derived Nanoformulation for the Management of Glioblastoma
   Chanam Melody Devi et al, 2024, Molecular Biotechnology CrossRef
4. Multidrug resistance, a major obstacle in hepatocellular carcinoma treatment: challenges and future perspectives
   Tarun Sahu et al, 2022, Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2 CrossRef
5. Mechanisms and cross-talk of regulated cell death and their epigenetic modifications in tumor progression
   Ruimin He et al, 2024, Molecular Cancer CrossRef
6. DNMT1 mediated promoter methylation of GNAO1 in hepatoma carcinoma cells
   Diannan Xu et al, 2018, Gene CrossRef
7. The Role of Apoptosis as a Double-Edge Sword in Cancer
   Reyhaneh Farghadani et al, 2022, Regulation and Dysfunction of Apoptosis CrossRef
8. MLKL deficiency in BrafV600EPten−/− melanoma model results in a modest delay of nevi development and reduced lymph node dissemination in male mice
   Sofie Martens et al, 2022, Cell Death & Disease CrossRef
9. Caspase-8 in inflammatory diseases: a potential therapeutic target
   Wangzheqi Zhang et al, 2024, Cellular & Molecular Biology Letters CrossRef
10. Therapeutic potential of marine peptides in glioblastoma: Mechanistic insights
    Salman Ahmed et al, 2021, Cellular Signalling CrossRef
11. Expression levels of EPHB4, EFNB2 and caspase‑8 are associated with clinicopathological features and progression of esophageal squamous cell cancer
    Qianzhi Ni et al, 2019, Oncology Letters CrossRef